Literature DB >> 25752712

Biliary tract: Therapeutic strategies for cholangiocarcinoma-wishing on WNT inhibitors?

Katrina Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25752712     DOI： 10.1038/nrgastro.2015.39

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.

Authors:  Luke Boulter; Rachel V Guest; Timothy J Kendall; David H Wilson; Davina Wojtacha; Andrew J Robson; Rachel A Ridgway; Kay Samuel; Nico Van Rooijen; Simon T Barry; Stephen J Wigmore; Owen J Sansom; Stuart J Forbes
Journal:  J Clin Invest       Date:  2015-02-17       Impact factor: 14.808
  1 in total
  2 in total

Review 1.  The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.

Authors:  Kosuke Mima; Keisuke Kosumi; Yoshifumi Baba; Tsuyoshi Hamada; Hideo Baba; Shuji Ogino
Journal:  Hum Genet       Date:  2020-11-12       Impact factor: 4.132

Review 2.  Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents.

Authors:  Federico Selvaggi; Teresa Catalano; Roberto Cotellese; Gitana Maria Aceto
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.